
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators Joseph A. Piechocki and Rafeeq A. Habeeb in Dec 2023. The observations cite lapses in investigations of equipment damage and potential particulate contamination, OOS investigations; deficiencies in sampling to ensure representativeness of the batch, deficiencies in cleaning, verification and maintenance of equipment, lapses in documentation and control. (USFDA 483)
Qvent review the observations in a series of 3 posts. In this post Qvents review the observations of Inadequate investigation into Equipment Damages, particulate contamination, OOS investigations
Other related posts are:
Leave a Comment
You must be logged in to post a comment.